1998 Jules Gonin Lecture of the Retina Research Foundation - Drug treatment of ocular neovascularization and proliferation

被引：2
作者：
Wiedemann, P
机构：
来源：
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 1999年 / 237卷 / 06期
关键词：
D O I：
10.1007/s004170050259
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：445 / 447
页数：3
相关论文
共 18 条
[1]  
AYLWARD G, 1997, COMMUNICATION
[2]   Pathogenic mechanisms in proliferative vitreoretinopathy [J].
Campochiaro, PA .
ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (02) :237-241
[3]   Factors controlling ocular angiogenesis [J].
Casey, R ;
Li, WW .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 124 (04) :521-529
[4]  
FAUDE F, 1999, IN PRESS RETINA
[5]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25
[6]   Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization [J].
Hammes, HP ;
Brownlee, M ;
Jonczyk, A ;
Sutter, A ;
Preissner, KT .
NATURE MEDICINE, 1996, 2 (05) :529-533
[7]   Signaling vascular morphogenesis and maintenance [J].
Hanahan, D .
SCIENCE, 1997, 277 (5322) :48-50
[8]  
HEIMANN K, 1998, WORKSH MAC TRANSL CO
[9]   Verapamil inhibits proliferation, migration and protein kinase C activity in human retinal pigment epithelial cells [J].
Hoffman, S ;
Gopalakrishna, R ;
Gundimeda, U ;
Murata, T ;
Spee, C ;
Ryan, SJ ;
Hinton, DR .
EXPERIMENTAL EYE RESEARCH, 1998, 67 (01) :45-52
[10]  
Hoffmann S., 1998, IOVS, V39, pS864
12